Get started

Johnson_and_johnson

Johnson & Johnson Technical AnalysisWait Before buying - check if the support level will not be broken before buying, otherwise hold Fundamental Analysis Johnson & Johnson (NYSE:JNJ) began researching vaccine candidates in January, as soon as the COVID-19 sequence became available. A Phase 1 clinical trial of the novel coronavirus vaccine is planned for September, with data regarding safety and efficacy available by the end of the year. If all goes accordingly, the vaccine could be ready “for emergency use” in early 2021. As part of this commitment, Johnson & Johnson will scale up its manufacturing capacity in the U.S. and other countries in order to enable the supply of more than 1 billion doses of the vaccine when it is ready.
NYSE:JNJ
by Mauriello
JNJ: Bearish Breakdown Analysis 4H (Apr. 26)X FORCE GLOBAL ANALYSIS: Johnson & Johnson has shown great momentum in its small rally over the past few weeks. However, technicals demonstrate signs of prices having temporarily topped out. Technical Analysis - The first thing we spot is a textbook bearish divergence. - Prices form higher highs, while the Relative Strength Index (RSI) forms lower highs - The Moving Average Convergence Divergence (MACD) has formed a death cross, with increasing bearish histograms - We have broken down from the ascending parallel channel, and the support has now become resisance - Prices have been testing the upper resistance of the Bollinger bands, and a test of the lower support is highly likely - We have two price gaps on the 4H chart, waiting to get potentially filled - The volume is decreasing as bearish tensions increase What We Believe Although JNJ is a fundamentally sound stock, and still great for the long run, short term technicals demonstrate a potential downside. Trade Safe.
NYSE:JNJShort
by XForceGlobal
JOHNSON & JOHNSON (JNJ) TOP-DOWN ANALYSIS & TRADING PLAN! hey guys, JNJ is retesting the major recently broken trendline. Chances are high that the market may drop from that and here is how we can catch this wave! pay attention to a horizontal decision range on 1H. bearish breakout of it will be a perfect trigger to short! initial target - 111.0 then apply trailing stop to catch occasional panic selloff. if the market goes above the falling trendline on 4H, our setups will be invalid and our bias shifts to bullish! good luck!
NYSE:JNJShort
by VasilyTrader
4
J&J vs opioids (Johnson is winning)Fundamental analysis In one of the first state opioid cases, an Oklahoma judge ruled against Johnson & Johnson, awarding the state $572 million, well below the over $17 billion the state was seeking in damages. Meaning... out of the 17 billion, they lost only 3.36%, and they expect to appeal the case, probably lowering this amount. Technical analysis On a technical analysis, I still think the risk reward ratio is too small to enter a position now. But technicals are good (not great). So I am keeping this on my watchlist.
NYSE:JNJ
by dorfmanmaster
Johnson & Johnson head and shouldersLooks like a right shoulder could be forming, weekly chart offers a nice view and divergence for the H&S pattern. A break to the low through 200SMA on a daily chart could signal a nice short. J&J tasked a Federal Judge to take over the 2400 lawsuits because of the baby powder fiasco so company is still dealing with the fallout. Could be a good trade for next week. Although earnings on Tuesday were positive there was no bullish spike. Have a great Easter weekend!
NYSE:JNJ
by Antonio_trader
$JNJ - Weekly Outlook Feb 25 - Mar 01$JNJ is in a up trending channel and pushing against the upper trend line of the channel. I am seeing resistance area at 137.80 - 138.30. It bounced off daily support nicely and headed straight up. I feel confident it will hit the first profit target 137.80 early next week. This is where you should be taking profits if you are in JNJ. If JNJ runs next week, second profit target 139.55 is also possible. I got into JNJ when I saw it successfully bounced off support and I will exit my position when it hits 137.80 which could be Monday or Tuesday (unless for any reason market sells off at the start of the week). For a longer-term JNJ perspective, Mar 04 looks to be the date when FDA is expected to give its approval on the JNJ's new depression drug. Once approved, JNJ can see a decent pump. US-China trade news can make it go in either direction. Deadline of Mar 01 is next week. Next week is news critical. Markets will make moves depending on what kind of trade-related news we get. If you would like me to analyse a stock ticker, please feel free to mention in the comments. News article for JNJ's new depression drug: www.businessinsider.com
NYSE:JNJLong
by Blackhole-Trading